Thymoquinone-entrapped chitosan-modified nanoparticles: formulation optimization to preclinical bioavailability assessments

References

• Abd El Hady WE, Mohamed EA, Soliman OA, El-Sabbagh HM. (2019). In vitro-in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin. Int J Nanomed 14:7191–213.
   PubMed Web of Science ®Google Scholar
• Aldawsari HM, Alhakamy NA, Padder R, et al. (2020). Preparation and characterization of chitosan coated PLGA nanoparticles of resveratrol: Improved stability, antioxidant and apoptotic activities in H1299 lung cancer cells. Coatings 10:e439.
   Web of Science ®Google Scholar
• Alhakamy NA, Aldawsari HM, Hosny KM, et al. (2020). Formulation design and pharmacokinetic evaluation of docosahexaenoic acid containing self-nanoemulsifying drug delivery system for oral administration. Nanomater Nanotechnol 10:1–11.
   Web of Science ®Google Scholar
• Almeida KB, Ramos AS, Nunes JB, et al. (2019). PLGA nanoparticles optimized by Box-Behnken for efficient encapsulation of therapeutic Cymbopogon citratus essential oil. Colloids Surf B Biointerfaces 181:935–42.
   PubMed Web of Science ®Google Scholar
• Alshehri S, Imam SS, Rizwanullah M, et al. (2020). Effect of chitosan coating on PLGA nanoparticles for oral delivery of thymoquinone: in vitro, ex vivo, and cancer cell line assessments. Coatings 11:e6.
   Web of Science ®Google Scholar
• Anwer MK, Mohammad M, Ezzeldin E, et al. (2019). Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats. Int J Nanomed 14:1587–95.
   PubMed Web of Science ®Google Scholar
• Badran MM, Alomrani AH, Harisa GI, et al. (2018). Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability. Biomed Pharmacother 106:1461–8.
   PubMed Web of Science ®Google Scholar
• Ballout F, Habli Z, Rahal ON, et al. (2018). Thymoquinone-based nanotechnology for cancer therapy: promises and challenges. Drug Discov Today 23:1089–98.
   PubMed Web of Science ®Google Scholar
• Bihari P, Vippola M, Schultes S, et al. (2008). Optimized suspension of nanoparticles for biological in vitro and in vivo studies. Part Fibre Toxicol 5:e14.
   PubMed Web of Science ®Google Scholar
• Coutinho AJ, Lima SA, Afonso CM, Reis S. (2020). Mucoadhesive and pH responsive fucoidan-chitosan nanoparticles for the oral delivery of methotrexate. Int J Biol Macromol 158:180–8.
   PubMed Web of Science ®Google Scholar
• Danaei M, Dehghankhold M, Ataei S, et al. (2018). Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics 10:e57.
   PubMed Web of Science ®Google Scholar
• Darakhshan S, Pour AB, Colagar AH, Sisakhtnezhad S. (2015). Thymoquinone and its therapeutic potentials. Pharmacol Res 95-96:138–58.
   PubMed Web of Science ®Google Scholar
• Dayan N, Touitou E. (2000). Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 21:1879–85.
   PubMed Web of Science ®Google Scholar
• de Souza MP, Sábio RM, de Cassia Ribeiro T, et al. (2020). Highlighting the impact of chitosan on the development of gastroretentive drug delivery systems. Int J Biol Macromol 159:804–22.
   PubMed Web of Science ®Google Scholar
• Delan WK, Zakaria M, Elsaadany B, et al. (2020). Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study. Int J Pharm 577:119038.
   PubMed Web of Science ®Google Scholar
• Elmowafy M, Samy A, Raslan MA, et al. (2016). Enhancement of bioavailability and pharmacodynamic effects of thymoquinone via nanostructured lipid carrier (NLC) formulation. AAPS PharmSciTech 17:663–72.
   PubMed Web of Science ®Google Scholar
• Fakhria A, Gilani SJ, Imam SS., Chandrakala (2019). Formulation of thymoquinone loaded chitosan nano vesicles: in-vitro evaluation and in-vivo anti-hyperlipidemic assessment. J Drug Deliv Sci Tech 50:339–46.
   Web of Science ®Google Scholar
• Gilani SJ, Bin-Jumah M, Rizwanullah M, et al. (2021). Chitosan coated luteolin nanostructured lipid carriers: optimization, in vitro-ex vivo assessments and cytotoxicity study in breast cancer cells. Coatings 11:e158.
   Web of Science ®Google Scholar
• Gilani SJ, Imam SS, Ahmed A, et al. (2019). Formulation and evaluation of thymoquinone niosomes: Application of developed and validated RP-HPLC method in delivery system. Drug Dev Ind Pharm 45:1799–806.
   PubMed Web of Science ®Google Scholar
• Guarino V, Gentile G, Sorrentino L, Ambrosio L. (2017). Polycaprolactone: synthesis, properties, and applications, In: K. Matyjaszewski (Ed), Encyclopedia of Polymer Science and Technology, John Wiley & Sons, Ltd, Rome, Italy, pp. 1–36.
   Google Scholar
• Jha SK, Karki R, Puttegowda VD, Harinarayana D. (2014). In vitro intestinal permeability studies and pharmacokinetic evaluation of famotidine microemulsion for oral delivery. Int Sch Res Not 2014:e452051.
   PubMedGoogle Scholar
• Kalam MA, Raish M, Ahmed A, et al. (2017). Oral bioavailability enhancement and hepatoprotective effects of thymoquinone by self-nanoemulsifying drug delivery system. Mater Sci Eng C Mater Biol Appl 76:319–29.
   PubMed Web of Science ®Google Scholar
• Kim BS, Kim CS, Lee KM. (2008). The intracellular uptake ability of chitosan-coated poly (D,L-lactideco-glycolide) nanoparticles. Arch Pharm Res 31:1050–4.
   PubMed Web of Science ®Google Scholar
• Lepeltier E, Bourgaux C, Couvreur P. (2014). Nanoprecipitation and the “Ouzo effect”: Application to drug delivery devices. Adv Drug Deliv Rev 71:86–97.
   PubMed Web of Science ®Google Scholar
• Lima IA, Khalil NM, Tominaga TT, et al. (2018). Mucoadhesive chitosan-coated PLGA nanoparticles for oral delivery of ferulic acid. Artif Cells Nanomed Biotechnol 46:993–1002.
   PubMed Web of Science ®Google Scholar
• Manjili HK, Malvandi H, Mousavi MS, et al. (2018). In vitro and in vivo delivery of artemisinin loaded PCL-PEG-PCL micelles and its pharmacokinetic study. Artif Cells Nanomed Biotechnol 46:926–36.
   PubMed Web of Science ®Google Scholar
• Mohammed MA, Syeda JTM, Wasan KM, Wasan EK. (2017). An overview of chitosan nanoparticles and its application in non-parenteral drug delivery. Pharmaceutics 9:e53.
   PubMed Web of Science ®Google Scholar
• Murthy A, Ravi PR, Kathuria H, Vats R. (2020). Self-assembled lecithin-chitosan nanoparticles improve the oral bioavailability and alter the pharmacokinetics of raloxifene. Int J Pharm 588:119731.
   PubMed Web of Science ®Google Scholar
• Pauluk D, Padilha AK, Khalil NM, Mainardes RM. (2019). Chitosan-coated zein nanoparticles for oral delivery of resveratrol: formation, characterization, stability, mucoadhesive properties and antioxidant activity. Food Hydrocol 94:411–7.
   Web of Science ®Google Scholar
• Rathore C, Rathbone MJ, Chellappan DK, et al. (2020). Nanocarriers: more than tour de force for thymoquinone. Expert Opin Drug Deliv 17:479–94.
   PubMed Web of Science ®Google Scholar
• Ritger PL, Peppas NA. (1987). A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release 5:37–42.
   Google Scholar
• Rizwanullah M, Amin S, Mir SR, et al. (2018). Phytochemical based nanomedicines against cancer: current status and future prospects. J Drug Target 26:731–52.
   PubMed Web of Science ®Google Scholar
• Shah M, Pathak K. (2010). Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 23 full-factorial design. AAPS PharmSciTech 11:489–96.
   PubMed Web of Science ®Google Scholar
• Shahab MS, Rizwanullah M, Alshehri S, Imam SS. (2020). Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: in vitro, ex vivo and toxicity assessments. Int J Biol Macromol 163:2392–404.
   PubMed Web of Science ®Google Scholar
• Sharma N, Madan P, Lin S. (2016). Effect of process and formulation variables on the preparation of parenteral paclitaxel‐loaded biodegradable polymeric nanoparticles: a cosurfactant study. Asian J Pharm Sci 11:404–16.
   Web of Science ®Google Scholar
• Sharma M, Sharma R, Jain DK, Saraf A. (2019). Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: optimization and pharmacokinetic study. Int J Biol Macromol 135:246–60.
   PubMed Web of Science ®Google Scholar
• Snehalatha M, Venugopal K, Saha RN. (2008). Etoposide-loaded PLGA and PCL nanoparticles I: preparation and effect of formulation variables. Drug Deliv 15:267–75.
   Web of Science ®Google Scholar
• Sudhakar S, Chandran SV, Selvamurugan N, Nazeer RA. (2020). Biodistribution and pharmacokinetics of thiolated chitosan nanoparticles for oral delivery of insulin in vivo. Int J Biol Macromol 150:281–8.
   PubMed Web of Science ®Google Scholar
• Tavares MR, de Menezes LR, Dutra Filho JC, et al. (2017). Surface-coated polycaprolactone nanoparticles with pharmaceutical application: structural and molecular mobility evaluation by TD-NMR. Polym Test 60:39–48.
   Web of Science ®Google Scholar
• Wong CY, Al-Salami H, Dass CR. (2018). The role of chitosan on oral delivery of peptide-loaded nanoparticle formulation. J Drug Target 26:551–62.
   PubMed Web of Science ®Google Scholar
• Xie J, Yang Z, Zhou C, et al. (2016). Nanotechnology for the delivery of phytochemicals in cancer therapy. Biotechnol Adv 34:343–53.
   PubMed Web of Science ®Google Scholar
• Yu X, Mu Y, Xu M, et al. (2017). Preparation and characterization of mucosal adhesive and two-step drug releasing cetirizine-chitosan nanoparticle. Carbohydr Polym 173:600–9.
   PubMed Web of Science ®Google Scholar
• Zare M, Mohammadi Samani S, Sobhani Z. (2018). enhanced intestinal permeation of doxorubicin using chitosan nanoparticles. Adv Pharm Bull 8:411–7.
   PubMed Web of Science ®Google Scholar